-
宫颈癌是在全球女性疾病中普遍存在的、发病率和致死率最高的癌症之一[1]。放疗适用于各期宫颈癌的治疗,是局部晚期宫颈癌不可替代的治疗手段,而辐射抗性是导致宫颈癌放疗后局部复发和远处转移的重要原因。
缺氧导致的肿瘤辐射抗性是影响放疗疗效的重要因素,缺氧诱导因子α家族(hypoxia-inducible factor-α family,HIFs)在其中发挥着关键作用。缺氧作为应激源可以调节去泛素化酶(deubiquitinase,DUB),泛素羧基末端水解酶L5(ubiquitin carboxyl-terminal hydrolase isozyme L5,UCHL5)是DUB泛素羧基末端水解酶家族成员,它可影响肿瘤细胞的DNA损伤修复[2]、周期调控[3]、凋亡[4]和增殖等生物进程。本研究旨在观察缺氧对宫颈癌Hela细胞UCHL5表达的影响,进一步探讨UCHL5对宫颈癌Hela细胞辐射敏感性的作用。
缺氧诱导的UCHL5增强宫颈癌Hela细胞辐射抗性
Hypoxia-induced UCHL5 expression enhanced radioresistance of Hela cells in cervical cancer
-
摘要:
目的 研究缺氧诱导的泛素羧基末端水解酶L5(UCHL5)在调节宫颈癌Hela细胞辐射敏感性中的作用。 方法 以宫颈癌Hela细胞为研究对象,1% O2条件下培养观察UCHL5表达水平的变化。采用Western blot和实时定量聚合酶链反应(PCR)检测慢病毒载体感染Hela细胞后稳定调变UCHL5的效率,转录本分为空白对照组、过表达对照组、过表达UCHL5组转录本1~4和沉默对照组、沉默UCHL5组转录本1~2。将实验所用的细胞分为过表达对照组、过表达UCHL5组、沉默对照组和沉默UCHL5组。采用流式细胞术检测8 Gy γ射线照射48 h后细胞的凋亡率;采用细胞克隆形成实验检测0、2、4、6 Gy γ射线单次照射培养2周后4组细胞的克隆形成率;采用3-(4,5-二甲基噻唑-2)-2,5-二苯基四氮唑溴盐(MTT)实验检测4组细胞培养1周后的增殖率以及联合0、2、4、6、8、10 Gy γ射线照射后的增殖率。使用基因表达谱数据动态分析癌症基因组图谱数据库宫颈癌组织和正常组织中抗缺氧诱导因子1α(HIF-1α)与UCHL5表达的相关性。采用双荧光素酶报告基因实验观察HIF-1α对UCHL5的激活作用。组间比较采用单样本t检验,采用Pearson检验进行相关性分析。 结果 缺氧可诱导宫颈癌Hela细胞UCHL5的表达。Western blot和实时定量PCR结果显示,感染后的Hela细胞可显著上调或下调UCHL5的表达,其中,过表达UCHL5组转录本2和沉默UCHL5组转录本2的表达均较高,所以选择此2种转录本进行后续实验。克隆形成实验结果显示,与接受相同剂量照射的过表达对照组相比,上调UCHL5增加了Hela细胞的克隆形成率,在0 、2、4、6 Gy剂量照射后克隆形成率的差异均有统计学意义( t=14.16、19.22、8.76、6.79,均 P<0.05)。 流式细胞术结果显示,与沉默对照组相比,沉默 UCHL5 促进了 Hela 细胞的凋亡(t=10.29,P<0.05),增加了 γ 射线诱导的细胞凋亡率 (t=52.01, P<0.05)。MTT 实验结果显示,与过表达对照组相比,上调 UCHL5 可升高宫颈癌 Hela 细胞的增殖率,增殖率在第3天时差异有统计学意义 (t=3.905,P<0.05);与过表达对照组相比,等剂量照射 UCHL5 上调组升高了受照细胞的增殖率,在剂量为6、8、10 Gy时,细胞的增殖率差异均有统计学意义(t=3.40、4.06、3.68,均P<0.05)。宫颈癌组织中 HIF-1α 表达水平和UCHL5 表达水平呈正相关(R=0.31,P<0.01),双荧光素酶报告基因结果显示 HIF-1α 结合并激活 UCHL5 启动子的活性,其活性增加了2.5倍(t=30.47,P<0.05)。 结论 缺氧条件下,宫颈癌Hela细胞中UHCL5的诱导表达降低了细胞的辐射敏感性,其潜在的机制可能与HIF-1α转录激活UCHL5的表达有关。 -
关键词:
- 低氧 /
- 宫颈肿瘤 /
- 辐射抗性 /
- 去泛素化酶 /
- 泛素羧基末端水解酶 L5
Abstract:Objective To investigate the role of hypoxia-induced ubiquitin carboxyl-terminal hydrolase isozyme L5 (UCHL5) in the regulation of radiosensitivity of Hela cells in cervical cancer. Methods UCHL5 levels were detected in Hela cells cultured under 1% O2 condition. Western blot and qRT-PCR analyses verified the efficiency of lentiviral vector infection on stable UCHL5 modulation in HeLa cells, including oe-vector, oe-UCHL5-1, oe-UCHL5-2, oe-UCHL5-3, oe-UCHL5-4 and sh-vector, sh-UCHL5-1 and sh-UCHL5-2. The cells used in the experiment were divided into the following groups: oe-vector, oe-UCHL5, sh-vector and sh-UCHL5. Cell colony-formation rate and radiosensitivity were detected by colony-formation assay combined with single-dose (0, 2, 4 and 6 Gy) γ-ray irradiation after culturing for 2 weeks. The effect of radiation on cell apoptosis was determined by flow cytometry after 48 h of 8 Gy γ-ray irradiation. 3-(4,5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide assay was used to detect the cell viability of down- or up-regulated UCHL5 cells before and after 0, 2, 4, 6, 8 and 10 Gy of γ-ray irradiation. Gene expression profiling interactive analysis was used to analyze the correlated expression between UCHL5 and hypoxia inducible factor-1α (HIF-1α). The transcriptional activation effect of UCHL5 by HIF-1α was detected using dual-luciferase reporter-gene assay. Differences between groups were compared by single-sample t test, and Pearson test was used for correlation analysis. Results UCHL5 was significantly induced by hypoxia after culturing at different time points. Hela cell lines with stably overexpressed and silenced UCHL5 were successfully constructed, with oe-UCHL5-2 and sh-UCHL5-2 having the highest regulatory efficiency. These two groups were selected for subsequent experiments. Compared with the control group that received the same dose of irradiation, significant differences existed at doses of 0, 2, 4 and 6 Gy (t=14.16, 19.22, 8.76, 6.79, all P<0.05), respectively. Knock-down of UCHL5 promoted apoptosis (t=10.29, P<0.05) and radiation-induced apoptosis (t=52.01, P<0.05). UCHL5 up-regulation promoted cell proliferation, and the proliferation rate was statistically significant on the third day (t=3.905, P<0.05). Furthermore, UCHL5 strengthened the viability (t=3.40, 4.06, 3.68, all P<0.05) of irradiated Hela cells, with significant differences at doses of 6, 8 and 10 Gy (t=3.40, 4.06, 3.68, all P<0.05), respectively. The expression levels of HIF-1α and UCHL5 in cervical cancer tissues were positively correlated (R=0.31, P<0.01). Additionally, HIF-1α was a potential transcriptional activator of UCHL5 in Hela cells, and its activity increased 2.5 times (t=30.47, P<0.05). Conclusions The induced expression of UHCL5 in cervical cancer Hela cells under hypoxia condition can reduce the radiation sensitivity of cells. The underlying mechanism may be related to the HIF-1α transcriptional activation of UCHL5 expression. -
图 6 上调和下调UCHL5 在8 Gy γ 射线照射前(A)、48 h后(B)宫颈癌 Hela 细胞Bcl-2 的表达量 UCHL5为泛素羧基末端水解酶L5;Bcl-2为B细胞淋巴瘤2;β-actin为β肌动蛋白
Figure 6. Bcl-2 expression levels before (A) and after (B) 48 h8 Gy γ-ray irradiation of up-regulated and down-regulated ubiquitin carboxyl-terminal hydrolase isozyme L5 expression levels in cervical cancer Hela cells
图 8 宫颈癌 UCHL5和 HIF-1α 表达水平的相关性(A)、UCHL5在人肾上皮293T细胞中对HIF-1α的靶向调控作用(B)
Figure 8. The correlation between the expression levels of ubiquitin carboxyl-terminal hydrolase isozyme L5 and hypoxia-inducible factor 1α in cervical cancer tissues (A) and targeted regulation of ubiquitin carboxyl-terminal hydrolase isozyme L5 on hypoxia-inducible factor 1α in human renal epitheliar 293T cells (B)
-
[1] Shrestha AD, Neupane D, Vedsted P, et al. Cervical cancer prevalence, incidence and mortality in low and middle income countries: a systematic review[J]. Asian Pac J Cancer Prev, 2018, 19(2): 319−324. DOI: 10.22034/APJCP.2018.19.2.319. [2] Nishi R, Wijnhoven P, Le Sage C, et al. Systematic characterization of deubiquitylating enzymes for roles in maintaining genome integrity[J]. Nat Cell Biol, 2014, 16(10): 1016−1026. DOI: 10.1038/ncb3028. [3] Randles L, Anchoori PK, Roden RBS, et al. The proteasome ubiquitin receptor hRpn13 and its interacting deubiquitinating enzyme uch37 are required for proper cell cycle progression[J]. J Biol Chem, 2016, 291(16): 8773−8783. DOI: 10.1074/jbc.M115.694588. [4] Chen ZW, Niu XM, Li ZM, et al. Effect of ubiquitin carboxy-terminal hydrolase 37 on apoptotic in A549 cells[J]. Cell Biochem Funct, 2011, 29(2): 142−148. DOI: 10.1002/cbf.1734. [5] Lee H, Kang Y, Ju W. Cervical cancer screening in developing countries: using visual inspection methods[J]. Clin J Oncol Nurs, 2016, 20(1): 79−83. DOI: 10.1188/16.CJON.79-83. [6] Vordermark D. Radiotherapy of cervical cancer[J]. Oncol Res Treat, 2016, 39(9): 516−520. DOI: 10.1159/000448902. [7] Huang EY, Wang CJ, Chen HC, et al. Multivariate analysis of para-aortic lymph node recurrence after definitive radiotherapy for stage IB-IVA squamous cell carcinoma of uterine cervix[J]. Int J Radiat Oncol Biol Phys, 2008, 72(3): 834−842. DOI: 10.1016/j.ijrobp.2008.01.035. [8] Nussenbaum F, Herman IM. Tumor angiogenesis: insights and innovations[J]. J Oncol, 2010, 2010: 132641. DOI: 10.1155/2010/132641. [9] Suh YE, Raulf N, Gäken J, et al. MicroRNA-196a promotes an oncogenic effect in head and neck cancer cells by suppressing annexin A1 and enhancing radioresistance[J]. Int J Cancer, 2015, 137(5): 1021−1034. DOI: 10.1002/ijc.29397. [10] Alsahafi E, Begg K, Amelio I, et al. Clinical update on head and neck cancer: molecular biology and ongoing challenges[J/OL]. Cell Death Dis, 2019, 10(8): 540[2020-10-21]. https://www.nature.com/articles/s41419-019-1769-9. DOI: 10.1038/s41419-019-1769-9. [11] Gray LH, Conger AD, Ebert M, et al. The concentration of oxygen dissolved in tissues at the time of irradiation as a factor in radiotherapy[J]. Br J Radiol, 1953, 26(312): 638−648. DOI: 10.1259/0007-1285-26-312-638. [12] Liu JY, Zhang J, Wang XW, et al. HIF-1 and NDRG2 contribute to hypoxia-induced radioresistance of cervical cancer Hela cells[J]. Exp Cell Res, 2010, 316(12): 1985−1993. DOI: 10.1016/j.yexcr.2010.02.028. [13] Arpalahti L, Laitinen A, Hagström J, et al. Positive cytoplasmic UCHL5 tumor expression in gastric cancer is linked to improved prognosis[J/OL]. PLoS One, 2018, 13(2): e0193125[2020-10-21]. https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0193125. DOI: 10.1371/journal.pone.0193125. [14] Xia XH, Liao YN, Guo ZQ, et al. Targeting proteasome-associated deubiquitinases as a novel strategy for the treatment of estrogen receptor-positive breast cancer[J/OL]. Oncogenesis, 2018, 7(9): 75[2020-10-21]. https://www.nature.com/articles/s41389-018-0086-y. DOI: 10.1038/s41389-018-0086-y. [15] Wang L, Chen YJ, Xu K, et al. High expression of UCH37 is significantly associated with poor prognosis in human epithelial ovarian cancer[J]. Tumour Biol, 2014, 35(11): 11427−11433. DOI: 10.1007/s13277-014-2446-3. [16] Fang Y, Fu D, Tang WQ, et al. Ubiquitin C-terminal hydrolase 37, a novel predictor for hepatocellular carcinoma recurrence, promotes cell migration and invasion via interacting and deubiquitinating PRP19[J]. Biochim Biophys Acta, 2013, 1833(3): 559−572. DOI: 10.1016/j.bbamcr.2012.11.020. [17] Chen YJ, Fu D, Xi JJ, et al. Expression and clinical significance of UCH37 in human esophageal squamous cell carcinoma[J]. Dig Dis Sci, 2012, 57(9): 2310−2317. DOI: 10.1007/s10620-012-2181-9. [18] Rolén U, Kobzeva V, Gasparjan N, et al. Activity profiling of deubiquitinating enzymes in cervical carcinoma biopsies and cell lines[J]. Mol Carcinog, 2006, 45(4): 260−269. DOI: 10.1002/mc.20177. [19] Zhang WL, Liu ZK, Wang JM, et al. Knockdown of USP28 enhances the radiosensitivity of esophageal cancer cells via the c-Myc/hypoxia-inducible factor-1 alpha pathway[J]. J Cell Biochem, 2019, 120(1): 201−212. DOI: 10.1002/jcb.27305. [20] Wu ZQ, Qiu MH, Guo Y, et al. OTU deubiquitinase 4 is silenced and radiosensitizes non-small cell lung cancer cells via inhibiting DNA repair[J/OL]. Cancer Cell Int, 2019, 19: 99[2020-10-21]. https://cancerci.biomedcentral.com/articles/10.1186/s12935-019-0816-z. DOI: 10.1186/s12935-019-0816-z. [21] Yang YF, Yang CZ, Li TT, et al. The deubiquitinase USP38 promotes NHEJ repair through regulation of HDAC1 activity and regulates cancer cell response to genotoxic insults[J]. Cancer Res, 2020, 80(4): 719−731. DOI: 10.1158/0008-5472.CAN-19-2149. [22] Li Q, Kluz T, Sun H, et al. Mechanisms of c-Myc degradation by nickel compounds and hypoxia[J/OL]. PLoS One, 2009, 4(12): e8531[2020-10-21]. https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0008531. DOI: 10.1371/journal.pone.0008531. [23] Wen YA, Stevens PD, Gasser ML, et al. Downregulation of PHLPP expression contributes to hypoxia-induced resistance to chemotherapy in colon cancer cells[J]. Mol Cell Biol, 2013, 33(22): 4594−4605. DOI: 10.1128/MCB.00695-13. [24] Shi JD, Liu YJ, Xu XH, et al. Deubiquitinase USP47/UBP64E regulates β-catenin ubiquitination and degradation and plays a positive role in wnt signaling[J]. Mol Cell Biol, 2015, 35(19): 3301−3311. DOI: 10.1128/MCB.00373-15. [25] Choi BJ, Park SA, Lee SY, et al. Hypoxia induces epithelial-mesenchymal transition in colorectal cancer cells through ubiquitin-specific protease 47-mediated stabilization of Snail: A potential role of Sox9[J/OL]. Sci Rep, 2017, 7(1): 15918[2020-10-21]. https://www.nature.com/articles/s41598-017-15139-5. DOI: 10.1038/s41598-017-15139-5. [26] Wu HW, Ying W, Wang W, et al. HIF1α and HIF2α mediated UCHL1 upregulation in hypoxia-induced neuronal injury following neuronal hypoxic ischemic encephalopathy[J]. Int J Clin Exp Pathol, 2016, 9(2): 2677−2685.